Translations:Lipid-lowering agent/7/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,166 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 21:44, 13 April 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Lipid-lowering agent)
==Research==
Investigational classes of hypolipidemic agents:
* [[CETP inhibitor]]s (cholesteryl ester transfer protein), 1 candidate is in trials. ([[Anacetrapib]]) It is expected that these drugs will mainly increase HDL while lowering LDL
* [[Squalene synthase inhibitor]]
* [[ApoA-1 Milano]]
* Succinobucol (AGI-1067), a novel antioxidant, failed a phase-III trial.
* Apoprotein-B inhibitor [[mipomersen]] (approved by the FDA in 2013 homozygous [[familial hypercholesterolemia]].).
* [[Bempedoic acid]], an ATP citrate lyase inhibitor

Research

Investigational classes of hypolipidemic agents:

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Lipid-lowering_agent/7/en&oldid=138956"